Apr 27, 2022 | News
Introduction On The Rising Tide Podcast, scientists from the independent, nonprofit Center for Genomic Interpretation discuss with leading experts the need to further raise the bar on accuracy and quality in clinical genetics, genomics, and precision medicine. Only...
Apr 20, 2022 | News
————— FDA WARNING to patients and healthcare providers published yesterday! Non-invasive prenatal screening (NIPS, also referred to as NIPT) is widely used but “none have yet been authorized, cleared, or approved by the FDA. The accuracy and performance of NIPS tests...
Apr 13, 2022 | News
————— “Researchers at City of Hope question the reliability and utility of Natera’s Signatera, highlighting the results as evidence that genomic minimal residual disease (MRD) testing may be at BEST unhelpful and at WORST unreliable in detecting recurrences earlier...
Apr 13, 2022 | News
————— 𝗙𝗗𝗔 𝗢𝗩𝗘𝗥𝗦𝗜𝗚𝗛𝗧 𝗡𝗘𝗘𝗗𝗘𝗗 𝗦𝗢 𝗟𝗔𝗕 𝗧𝗘𝗦𝗧𝗦 𝗗𝗢 𝗠𝗢𝗥𝗘 𝗚𝗢𝗢𝗗 𝗧𝗛𝗔𝗡 𝗛𝗔𝗥𝗠 𝐓𝐡𝐞 Center for Genomic Interpretation (CGI) 𝐬𝐮𝐩𝐩𝐨𝐫𝐭𝐬 𝐭𝐡𝐞 𝗩𝗔𝗟𝗜𝗗 (𝗩𝗲𝗿𝗶𝗳𝘆𝗶𝗻𝗴 𝗔𝗰𝗰𝘂𝗿𝗮𝘁𝗲, 𝗟𝗲𝗮𝗱𝗶𝗻𝗴-𝗲𝗱𝗴𝗲 𝗜𝗩𝗖𝗧 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁) 𝗔𝗰𝘁. This bill was introduced in Congress in December 2018, but is picking up momentum...
Apr 13, 2022 | News
Is ACCURACY of a FDA-Approved Companion Diagnostic (CDx) SUPERIOR to a Laboratory Developed Test (LDT)? If you don’t know the answer (or even if you think you do), please read on! ————— Does a Laboratory Developed Test (LDT) identify ALL variants or mutations? How...
Recent Comments